KRKA, d.d., Novo mesto (secondary packaging, batch control and batch release) / KRKA, d.d., Novo mesto (manufacturing 'in bulk', primary and secondary packaging)
UkraineAll drugs from this manufacturer
-
The drug is prescribed for the treatment of upper respiratory tract infections (tonsillitis, pharyngitis), paranasal sinus infections, lower respiratory tract infections (bronchitis, pneumonia), acute otitis media, as well as skin infections, soft tissue infections, and mycobacterial infections.
Dosage form: granules for oral suspension
Active substance Dosage clarithromycin 125 mg/5 ml ATC: J01FA09